Individuals Discontinuing Anti-Obesity Medications Regain Weight Four Times Faster Compared to People Using Diet and Exercise

New research suggests that patients who come off new GLP-1 drugs like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop conventional diet and exercise programs.

Research printed in a major medical journal demonstrates that while overweight people often shed about a fifth of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.

"People purchasing these treatments need to be cognizant of the danger of fast weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to starting weight within about one and a half years.

Analyzing Approaches

The study, which looked at dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with other pills.

Scientists point out that people who shed pounds through diet and exercise usually have a slower creep back—approximately 0.1 kg a month—once they finish.

Explaining the Rapid Regain

Doctors propose the mechanism of the jabs is key to understanding the accelerated rebound.

GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate appetite.

"Sustained high doses of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making overeating far more likely."

A Chronic Disease?

The NHS suggest the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Professionals say that, given the likelihood of weight regain, the treatment should be considered ongoing.

This view is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of excess weight," akin to managing diseases like diabetes.

Patient Experiences

People who have come off the medication describe a intense return of appetite.

"It was like a trigger flipping and you become ravenous," recalled one woman.

The struggle is exacerbated if individuals have not adopted lasting lifestyle or habit modifications during therapy.

Significant Adoption

Recent estimates indicate that millions of people in the UK have tried these injections in the last 12 months, with interest being substantial.

• Adoption is more common among females compared to men.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion access the medications through private healthcare rather than public health services.

In conclusion, researchers caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and long-term success relies on integrated lifestyle changes.